Compare Goodyear Tire & Rubber Co (GT) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goodyear Tire & Rubber Co vs Hinge Health Inc. Class A Common Stock — how do they compare? Goodyear Tire & Rubber Co trades at $4.39 (market cap $1.31B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 6.5× Goodyear Tire & Rubber Co's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 58 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| GT | HNGE | |
|---|---|---|
Market Cap | $1.31B | $8.48B |
Volume | 8,331,802 | 879,799 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $105.14 |
52-Week Low | $4.38 | $31.17 |
Typical Hold Time | 58 Days | 0 Days |
Enterprise Value | $8.66B | $8.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The Goodyear Tire & Rubber Company (GT) trades at $4.38, down 2.45% on the day, reflecting persistent bearish technical momentum. The stock shows deeply discounted valuation ratios, including a P/E of 4.69 and P/B of 0.46, but faces significant fundamental challenges with a net income margin of -14.37% and negative ROE of -63.93% for 2025. Recent earnings have been mixed, with Q2 2026 beating expectations but still posting a loss. Cash flow trends show modest improvement, with net cash flow turning positive in 2025 and 2026. Analyst sentiment is mixed, with a consensus price target of $8.00 implying substantial upside, though technical indicators remain bearish overall.
Outlook: GT presents a high-risk, high-reward opportunity. The stock is fundamentally undervalued, and successful execution of its restructuring and margin expansion strategy could drive significant appreciation toward the analyst target. However, persistent losses, high debt, and competitive pressures pose substantial risks. Investors should weigh the potential for a turnaround against the company's current financial instability and bearish market sentiment.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Goodyear Tire & Rubber Co
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
